Clinical Trial Update: First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction

View source ↗

Summary

A clinical trial update suggests that the first trough level of tacrolimus is a better predictor for dosing than CYP3A5 genotyping in kidney transplant recipien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chulalongkorn University | Conditions: Kidney Transplantation Recipients | Status: UNKNOWN